A new oncology tracking service monitors key cancer-specific measures across 33 tumor types.

SDI's (Plymouth Meeting, PA, USA) new innovation to study and profile the oncology market is called the Oncology Tracker. To track the oncology market, a full Continuum of Care needs to be considered. Oncology Tracker utilizes the power of three unique types of data in one easy-to-use online tool.

Oncology Tracker fuses prescription data, medical claims data, and oncology-based electronic medical records to monitor 33 tumor types and provides detailed information on key measures, including staging, morphology, and both infused and oral therapies. Oncology Tracker comes complete with the following analyses: (1) market summary/market shift analysis, which provides a summary of projected tumor activities and shows top product use along with shifts from prior time periods; (2) market share analysis provides projected tumor market sizing along with product and regimen utilization; (3) line of therapy analysis tracks patient behavior through disease and therapy progression for both the current and two-year trended period; (4) dosing analysis, which studies dosing patterns for all agents used to treat given tumor types. Oncology Tracker fuses all these data to provide a better oncology insight.

SDI is a healthcare analytics organization that provides innovative services that help the healthcare industry solve a wide range of business challenges. The company's clients include all of the top 50 pharmaceutical/biopharmaceutical manufacturers, medical and surgical device manufacturers, retailers, and manufacturers of consumer packaged goods, the US government, financial institutions, media groups, and other top healthcare organizations.

Guangzhou Jia Yu medical equipment Limited